| Jun 17 |
Aerovate Therapeutics Stock Dropped Over 90%. Here’s Why.
|
| Jun 17 |
Top Midday Decliners
|
| Jun 17 |
Why 90% Of Aerovate Therapeutics' Value Just Went Up In Smoke
|
| Jun 17 |
Why Is Small Cap-Heart Disease Focused Aerovate Therapeutics Stock Plummeting On Monday?
|
| Jun 17 |
Aerovate Therapeutics slides after its hypertension treatment fails to meet main goal
|
| Jun 17 |
Aerovate Therapeutics Announces 24-Week Topline Results from the Phase 2b Portion of IMPAHCT Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension
|
| Jun 11 |
Aerovate: Imatinib Delivery Change Leads To Targeting Of Massive PAH Market
|
| Jun 11 |
Aerovate Therapeutics files for $350M mixed securities shelf
|
| Jun 6 |
Here's Why We're Watching Aerovate Therapeutics' (NASDAQ:AVTE) Cash Burn Situation
|
| May 21 |
Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American Thoracic Society 2024 International Conference
|
